Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-liver transplant CRE decolonization to prevent post-transplant CRE infection
ChiCTR2100048418Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jul 2021
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of gentamicin in Enterobacteriaceae colonization and Infection (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Incidence of CRE infection. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
gentamicin
03
Conditions
Enterobacteriaceae colonizationInfection
Beyond the preview
Go deeper on ChiCTR2100048418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048418.